Search Results - Eric A Ottesen

Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. by K D Ramaiah, Eric A Ottesen

Connect to this object online.

Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA). by Cathy Steel, Joseph Kubofcik, Eric A Ottesen, Thomas B Nutman

Connect to this object online.

The global programme to eliminate lymphatic filariasis: health impact after 8 years. by Eric A Ottesen, Pamela J Hooper, Mark Bradley, Gautam Biswas

Connect to this object online.

Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis. by Pamela J Hooper, Brian K Chu, Alexei Mikhailov, Eric A Ottesen, Mark Bradley

Connect to this object online.

The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). by Brian K Chu, Pamela J Hooper, Mark H Bradley, Deborah A McFarland, Eric A Ottesen

Connect to this object online.

Global programme to eliminate lymphatic filariasis: the processes underlying programme success. by Kazuyo Ichimori, Jonathan D King, Dirk Engels, Aya Yajima, Alexei Mikhailov, Patrick Lammie, Eric A Ottesen

Connect to this object online.

Predictive vs. empiric assessment of schistosomiasis: implications for treatment projections in Ghana. by Achille Kabore, Nana-Kwadwo Biritwum, Philip W Downs, Ricardo J Soares Magalhaes, Yaobi Zhang, Eric A Ottesen

Connect to this object online.

National mass drug administration costs for lymphatic filariasis elimination. by Ann S Goldman, Victoria H Guisinger, Moses Aikins, Maria Lourdes E Amarillo, Vicente Y Belizario, Bertha Garshong, John Gyapong, Conrad Kabali, Hussein A Kamal, Sanjat Kanjilal, Dominique Kyelem, Jefrey Lizardo, Mwele Malecela, Godfrey Mubyazi, P Abdoulaye Nitièma, Reda M R Ramzy, Thomas G Streit, Aaron Wallace, Molly A Brady, Richard Rheingans, Eric A Ottesen, Anne C Haddix

Connect to this object online.

A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. by Katherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, Mark Bradley, Peter U Fischer, John Gyapong, Makoto Itoh, Nese Ituaso-Conway, Hayley Joseph, Dominique Kyelem, Sandra J Laney, Anne-Marie Legrand, Tilaka S Liyanage, Wayne Melrose, Khalfan Mohammed, Nils Pilotte, Eric A Ottesen, Catherine Plichart, Kapa Ramaiah, Ramakrishna U Rao, Jeffrey Talbot, Gary J Weil, Steven A Williams, Kimberly Y Won, Patrick Lammie

Connect to this object online.

Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. by Brian K Chu, Michael Deming, Nana-Kwadwo Biritwum, Windtaré R Bougma, Améyo M Dorkenoo, Maged El-Setouhy, Peter U Fischer, Katherine Gass, Manuel Gonzalez de Peña, Leda Mercado-Hernandez, Dominique Kyelem, Patrick J Lammie, Rebecca M Flueckiger, Upendo J Mwingira, Rahmah Noordin, Irene Offei Owusu, Eric A Ottesen, Alexandre Pavluck, Nils Pilotte, Ramakrishna U Rao, Dilhani Samarasekera, Mark A Schmaedick, Sunil Settinayake, Paul E Simonsen, Taniawati Supali, Fasihah Taleo, Melissa Torres, Gary J Weil, Kimberly Y Won

Connect to this object online.